192 results on '"Horninger, Wolfgang"'
Search Results
2. 1491 IMMUNOHISTOCHEMICAL ERG STATUS IS NOT PREDICTIVE FOR BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY WITH POSITIVE SURGICAL MARGIN
3. 61 LONGTERM FOLLOW-UP OF MICROSOCOPIC MICROHEMATURIA AFTER NEGATIVE DIAGNOSTIC WORK-UP
4. 1611 QUANTITATIVE MEASUREMENT OF THE ANDROGEN RECEPTOR IN PREPUCES OF BOYS WITH AND WITHOUT HYPOSPADIAS
5. 1332 CORRELATION OF BIOPSY GLEASON SCORE AND GLEASON SCORE OF THE CORRESPONDING RADICAL PROSTATECTOMY SPECIMEN IN PATIENTS WHO MET THE INCLUSION CRITERIA FOR ACTIVE SURVEILLANCE
6. 2223 ERG GENE REARRANGEMENT IS MORE FREQUENT IN EARLY-ONSET PROSTATE CANCER AND IS ASSOCIATED WITH LOWER PSA SERUM LEVELS IN YOUNGER PATIENTS IN A PSA SCREENING COHORT
7. 848 PSA-ISOFORMS-VELOCITY: EVALUATION OF A NOVEL APPROACH IN THE EARLY DIAGNOSIS OF PROSTATE CANCER: RESULTS OF THE TYROL SCREENING PROJECT
8. 1197 THE WORST CANCERS SEND EARLY PSA SIGNALS THAT WOULD ALLOW EARLY DETECTION IF MONITORING FOCUSED ON INCREASING PSA
9. 2127 P2PSA IN COMBINATION WITH TOTAL PSA AND FREE PSA IMPROVES DIAGNOSTIC ACCURACY IN PROSTATE CANCER DETECTION
10. 410 LAMIN A/C IS A POTENTIAL DISCRIMINATORY BIOMARKER OF LOW AND HIGH GRADE PROSTATE CANCER
11. 1728 EARLY DETECTION OF PROSTATE CANCER (TYROL PROSTATE CANCER DEMONSTRATION PROJECT 1988-2008): 20 YEARS EXPERIENCE
12. 2153 PSAV FROM LONG-TERM, CONSISTENT PSA TRENDS HELPS IDENTIFY THE WORST CANCERS AND DISTINGUISH THEM FROM THE BEST CANCERS – RESULTS FROM THE TYROL CANCER DEMONSTRATION PROJECT
13. THE ROLE OF CONTRAST-ENHANCED ULTRASOUND TARGETED PROSTATE BIOPSY IN MEN WITH PREVIOUS NEGATIVE BIOPSY AND RISING PROSTATE-SPECIFIC ANTIGEN
14. Annexin A3 in Urine: A Highly Specific Noninvasive Marker for Prostate Cancer Early Detection
15. ONE CORE GLEASON SCORE 6 PROSTATE CANCER: CLINICALLY INSIGNIFICANT PROSTATE CANCER?
16. EVALUATION OF INVESTIGATOR DEPENDENCY IN TRANSRECTAL CONTRAST ENHANCED COLOR DOPPLER TARGETED BIOPSY
17. CONTRAST ENHANCED COLOR DOPPLER TARGETED BIOPSY: VALUE OF BLOOD FLOW RATING SCALE FOR PROSTATE CANCER DETECTION
18. DISCREPANCIES IN GLEASON SCORING OF PROSTATE BIOPSIES AND RADICAL PROSTATECTOMY SPECIMENS AND THE PROGNOSTIC VALUE OF PSAV ON SCORING ACCURACY. TEN YEAR EXPERIENCE IN A SINGLE CENTRE
19. MICROVASCULAR IMAGING (MVI) OF THE PROSTATE DURING CONTRAST-ENHANCED ULTRASOUND: INITIAL EXPERIENCE
20. OUTCOME OF RADICAL PROSTATECTOMY IN LOW, INTERMEDIATE AND HIGH RISK PROSTATE CANCER PATIENTS: A COMPARISON BETWEEN A SCREEN AND NON SCREEN POPULATION
21. THE USE OF -2proPSA AND BPSA IN PROSTATE CANCER DETECTION: EXTERNAL CROSS-VALIDATION OF A PREDICTIVE MODEL
22. PREDICTIVE VALUE OF PROSTATE SPECIFIC ANTIGEN VELOCITY IN THE DIAGNOSIS OF PROSTATE CANCER: RESULTS OF THE TYROL SCREENING PROJECT
23. THE TYROL PROSTATE CANCER DEMONSTRATION PROJECT (1988 - 2007): MORBIDITY AND MORTALITY
24. TRANSURETHRAL RESECTION OF THE PROSTATE WITH THE “COAGULATING INTERMITTENT CUTTING DEVICE”(CIC): IMPACT ON HEMOSTATIC COMPLICATIONS – AN UPDATE ON A 7 YEAR EXPERIENCE
25. CLINICAL AND PATHOLOGICAL CHARACTERISTICS OF PROSTATE CANCER IN MEN YOUNGER THAN 45 YEARS: RESULTS FROM THE TYROL PSA SCREENING PROJECT
26. CONTRAST ENHANCED COLOR DOPPLER TARGETED PROSTATE BIOPSY FOR PROSTATE CANCER DETECTION: RESULTS OF 2008 MEN
27. THE ROLE OF PROSTATE-SPECIFIC ANTIGEN VELOCITY IN PREDICTING NON-ORGAN-CONFINED PROSTATE CANCERS IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY
28. Under Diagnosis and Over Diagnosis of Prostate Cancer in a Screening Population With Serum PSA 2 to 10 ng/ml
29. 1422: Increased PSAV is Significantly Associated with Higher Gleason Scores in Patients Undergoing Radical Prostatectomy
30. 1747: Can preoperative PSA Velocity Serve as a Predictor of over- and/or Underdiagnosis in Patients Undergoing Radical Prostatectomy?
31. 4: Continence Outcomes in 324 Consecutive Patients Undergoing Robotic Prostatectomy-A Comparison of Two Techniques
32. 1749: Correlation between Initial total PSA and PSA Velocity in men with and without Biopsy-Proven Prostate Cancer
33. 1733: Transurethral Prostatectomy: Long Term Morbidity after a follow up of 15 Years
34. 161: Robot-Assisted Laparoscopic Pyeloplasty - 5-Year Follow-Up in a Single Center
35. 1022: Pathological Features of Gleason Score 6 Prostate Cancers in the Low and in the Intermediate TPSA Range: Is there a Difference?
36. 1746: Prostate Cancer Risk: The Significance of age-related Differences in PSA Velocity between Men with and without Biopsy-Proven Prostate Cancers
37. 1887: Overdiagnosis and Underdiagnosis of Screen vs. Non Screen Detected Prostate Cancers with TPSA Values of 2.0- 10.0 NG/ML
38. 154: Integration of TPSA and High-Throughput Mass Spectrometry Data Improves Prostate Cancer Prediction
39. 2: Predictive Factors for Return of Sexual Function after Robotic Radical Prostatectomy
40. 1428: The Role of Prostate-Specific Antigen Velocity in Predicting Non-Organ-Confined Prostate Cancers in Patients Undergoing Radical Prostatectomy
41. 1756: The Tyrol Prostate Cancer Demonstration Project (1988-2006): Early Detection, Treatment, Outcome, Incidence and Mortality
42. 1761: Underdiagnosis and Overdiagnosis of Prostate Cancer in a Screening Population with PSA-Values of 2 - 10ng/ml
43. 652: Anatomical Foundations of the Anatomic Reconstruction Technique of Continence
44. 851: Clinical and Pathological Features of Screen VS. Non Screen Detected Prostate Cancers: Is there a Difference?
45. 607: Low PSA Levels Cannot Rule out Prostate Cancer:Prostate Cancer Detection Rates with Respect to PSA Levels Results from a PSA Based Screening Cohort
46. 1506: Comparison of Real-Time Elastography Targeted Biopsy with Conventional Systematic Biopsy: Impact on Prostate Cancer Detection
47. 1155: Neuroanatomic Maps for Nerve Sparing Robotic Prostatectomy: A Study Describing the Importance of the Neurovascular Plate and its Relationship to the Steps of Surgery
48. 483: Is there a Normal PSA Value?
49. The Expression of Transcription Factor Activating Transcription Factor 3 in the Human Prostate and its Regulation by Androgen in Prostate Cancer
50. 485: PSA-Velocity Increases Continuously in the Years Prior to Diagnosis of Prostate Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.